Ship Healthcare Holdings Inc
TSE:3360
Ship Healthcare Holdings Inc
TSE:3360
Price:
2 426.5 JPY
-0.45%
Market Closed
Updated:
May 15, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
6.6
Current
7.6
Median
12.9
Industry
Lower
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=6.6
Enterprise Value
/
202.9B
EBITDA
30.7B
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| JP |
|
Ship Healthcare Holdings Inc
TSE:3360
|
228.9B JPY | 6.6 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
71.9B USD | 16 | |
| US |
|
Cencora Inc
NYSE:COR
|
44.5B USD | 11.8 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 11.3 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
23.9B USD | 8.9 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.5B USD | 12.4 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
70.4B HKD | 1.8 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 59.9 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.7B EUR | 15.9 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 15.2 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
53B CNY | 8.3 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
6.2
2-Years Forward
EV/EBITDA
5.9
3-Years Forward
EV/EBITDA
5.7
You don't have any saved screeners yet
